These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
|
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
|
(State of other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Address of principle executive offices)
|
|
(Zip Code)
|
|
(
|
|
(Registrant’s telephone number, including area code)
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
Large accelerated filer
☐
|
|
|
|
|
|
|
|
|
|
Non-accelerated filer
☐
|
|
Smaller reporting company
|
Emerging growth company
|
|
Class
|
|
Outstanding at July 31, 2020
|
|
Class A Common Stock, .001 par value
|
|
|
|
Class B Common Stock, .001 par value
|
|
|
|
PART I.
|
FINANCIAL INFORMATION
|
Page
|
|
|
|
|
|
Item 1.
|
1
|
|
|
|
|
|
|
Item 2.
|
24
|
|
|
|
|
|
|
Item 3.
|
32
|
|
|
|
|
|
|
Item 4.
|
32
|
|
|
|
|
|
|
PART II.
|
OTHER INFORMATION *
|
|
|
|
|
|
|
Item 1.
|
33
|
|
|
|
|
|
|
Item 2.
|
34
|
|
|
|
|
|
|
Item 6.
|
34
|
|
|
|
|
|
|
|
34
|
|
|
June 30,
2020
|
December 31,
2019
|
||||||
|
ASSETS
|
||||||||
|
Cash and cash equivalents (a)
|
$
|
|
$
|
|
||||
|
Investments in debt securities (a)
|
|
|
||||||
|
Investments in equity securities (Including GBL stock with a value of $
|
|
|
||||||
|
Investments in affiliated registered investment companies
|
|
|
||||||
|
Investments in partnerships (a)
|
|
|
||||||
|
Receivable from brokers (a)
|
|
|
||||||
|
Investment advisory fees receivable
|
|
|
||||||
|
Receivable from affiliates
|
|
|
||||||
|
Deferred tax assets (including taxes receivable of $
|
|
|
||||||
|
Goodwill
|
|
|
||||||
|
Other assets (a)
|
|
|
||||||
|
Total assets
|
$
|
|
$
|
|
||||
|
|
||||||||
|
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY
|
||||||||
|
Payable to brokers
|
$
|
|
$
|
|
||||
|
Income taxes payable
|
|
|
||||||
|
Compensation payable
|
|
|
||||||
|
Securities sold, not yet purchased (a)
|
|
|
||||||
|
Payable to affiliates
|
|
|
||||||
|
Accrued expenses and other liabilities (a)
|
|
|
||||||
|
Total liabilities
|
|
|
||||||
|
|
||||||||
|
Redeemable noncontrolling interests (a)
|
|
|
||||||
|
|
||||||||
|
Equity:
|
||||||||
|
Preferred stock, $
|
|
|
||||||
|
Class A Common Stock, $
|
|
|
||||||
|
Class B Common Stock, $
|
||||||||
|
|
|
|
||||||
|
Additional paid-in capital
|
|
|
||||||
|
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
|
Treasury stock, at cost (
|
(
|
)
|
(
|
)
|
||||
|
Total Associated Capital Group, Inc. equity
|
|
|
||||||
|
Noncontrolling interests
|
|
|
||||||
|
Total equity
|
|
|
||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
||||
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Investment advisory and incentive fees
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Institutional research services
|
|
|
|
|
||||||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Total revenues
|
|
|
|
|
||||||||||||
|
Expenses
|
||||||||||||||||
|
Compensation
|
|
|
|
|
||||||||||||
|
Stock-based compensation
|
|
|
(
|
)
|
|
|||||||||||
|
Other operating expenses
|
|
|
|
|
||||||||||||
|
Total expenses
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Other income (expense)
|
||||||||||||||||
|
Net gain/(loss) from investments
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Interest and dividend income
|
|
|
|
|
||||||||||||
|
Interest expense
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
|
Shareholder-designated contribution
|
|
|
(
|
)
|
|
|||||||||||
|
Total other income (expense), net
|
|
|
(
|
)
|
|
|||||||||||
|
Income/(loss) before income taxes
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Income tax expense/(benefit)
|
|
(
|
)
|
(
|
)
|
|
||||||||||
|
Net income/(loss)
|
|
|
(
|
)
|
|
|||||||||||
|
Net income/(loss) attributable to noncontrolling interests
|
|
|
(
|
)
|
|
|||||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||
|
|
||||||||||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share:
|
||||||||||||||||
|
Basic
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||
|
Diluted
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||
|
|
||||||||||||||||
|
Weighted average shares outstanding:
|
||||||||||||||||
|
Basic
|
|
|
|
|
||||||||||||
|
Diluted
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
Dividends declared:
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Net income/(loss)
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
|
Less: Comprehensive income/(loss) attributable to noncontrolling interests
|
|
|
(
|
)
|
|
|||||||||||
|
|
||||||||||||||||
|
Comprehensive income/(loss) attributable to Associated Capital Group, Inc.
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||
|
|
Associated Capital Group, Inc. shareholders
|
|||||||||||||||||||||||||||
|
Common
Stock
|
Accumulated
Deficit
|
Additional
Paid-in
Capital
|
Treasury
Stock
|
Noncontrolling
Interest
|
Total
|
Redeemable
Noncontrolling
Interests
|
||||||||||||||||||||||
|
Balance at December 31, 2019
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Redemptions of noncontrolling interests
|
|
|
|
|
|
|
(
|
)
|
||||||||||||||||||||
|
Net loss
|
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||||||||||
|
Purchase of treasury stock
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||
|
Balance at March 31, 2020
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Redemptions of noncontrolling interests
|
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Net income/(loss)
|
|
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||||||
|
Dividends declared ($0.10 per share)
|
(
|
)
|
|
|
(
|
)
|
|
|||||||||||||||||||||
|
Purchase of treasury stock
|
|
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||||||
|
Balance at June 30, 2020
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
|
Associated Capital Group, Inc. shareholders
|
|||||||||||||||||||||||
|
Common
Stock
|
Accumulated
Deficit
|
Additional
Paid-in
Capital
|
Treasury
Stock
|
Total
|
Redeemable
Noncontrolling
Interests
|
|||||||||||||||||||
|
Balance at December 31, 2018
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||
|
Redemptions of noncontrolling interests
|
|
|
|
|
|
(
|
)
|
|||||||||||||||||
|
Net income
|
|
|
|
|
|
|
||||||||||||||||||
|
Purchase of treasury stock
|
|
|
|
(
|
)
|
(
|
)
|
|
||||||||||||||||
|
Balance at March 31, 2019
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||
|
Redemptions of noncontrolling interests
|
|
|
|
|
|
(
|
)
|
|||||||||||||||||
|
Net income
|
|
(
|
)
|
|
|
(
|
)
|
|
||||||||||||||||
|
Dividends declared ($
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
|
Purchase of treasury stock
|
|
|
|
(
|
)
|
(
|
)
|
|
||||||||||||||||
|
Balance at June 30, 2019
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||||||
|
|
Six Months Ended
June 30,
|
|||||||
|
2020
|
2019
|
|||||||
|
Operating activities
|
||||||||
|
Net income (loss)
|
$
|
(
|
)
|
$
|
|
|||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||
|
Equity in net (gains) losses from partnerships
|
|
(
|
)
|
|||||
|
Deferred income taxes
|
(
|
)
|
(
|
)
|
||||
|
Depreciation and amortization
|
|
|
||||||
|
Donated securities
|
|
|
||||||
|
Unrealized (gains) losses on securities
|
|
(
|
)
|
|||||
|
Realized gains (losses) on sales of securities
|
|
(
|
)
|
|||||
|
(Increase) decrease in assets:
|
||||||||
|
Investments in trading securities
|
(
|
)
|
(
|
)
|
||||
|
Investments in partnerships:
|
||||||||
|
Contributions to partnerships
|
(
|
)
|
(
|
)
|
||||
|
Distributions from partnerships
|
|
|
||||||
|
Receivable from affiliates
|
|
|
||||||
|
Receivable from brokers
|
|
|
||||||
|
Investment advisory fees receivable
|
|
|
||||||
|
Income taxes receivable
|
(
|
)
|
|
|||||
|
Other assets
|
|
|
||||||
|
Increase (decrease) in liabilities:
|
||||||||
|
Payable to brokers
|
(
|
)
|
|
|||||
|
Income taxes payable
|
(
|
)
|
|
|||||
|
Payable to affiliates
|
(
|
)
|
(
|
)
|
||||
|
Compensation payable
|
(
|
)
|
(
|
)
|
||||
|
Accrued expenses and other liabilities
|
(
|
)
|
|
|||||
|
Total adjustments
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in operating activities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
|
Six Months Ended
June 30,
|
|||||||
|
2020
|
2019
|
|||||||
|
Investing activities
|
||||||||
|
Purchases of securities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
|
Proceeds from sales of securities
|
|
|
||||||
|
Return of capital on securities
|
|
|
||||||
|
Purchase of building
|
(
|
)
|
(
|
)
|
||||
|
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
|
|
||||||||
|
Financing activities
|
||||||||
|
Redemptions of redeemable noncontrolling interests
|
(
|
)
|
(
|
)
|
||||
|
Dividends paid
|
(
|
)
|
(
|
)
|
||||
|
Purchase of treasury stock
|
(
|
)
|
(
|
)
|
||||
|
Proceeds from promissory note from Executive Chairman
|
|
|
||||||
|
Repayment of promissory note to Executive Chairman
|
|
(
|
)
|
|||||
|
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
||||
|
Net decrease in cash and cash equivalents
|
(
|
)
|
(
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
|
|
||||||
|
Increase in cash from consolidation
|
|
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
||||
|
|
||||||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Cash paid for interest
|
$
|
|
$
|
|
||||
|
Cash paid for taxes
|
$
|
|
$
|
|
||||
|
|
||||||||
|
Reconciliation to cash, cash equivalents and restricted cash
|
||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Restricted cash included in receivable from brokers
|
|
|
||||||
|
Cash, cash equivalents and restricted cash
|
$
|
|
$
|
|
||||
|
a.
|
Asset-based advisory fees – The Company receives a management fee, payable monthly in advance based on value of the net assets of the client. It is generally set at a rate of
|
|
b.
|
Performance-based advisory fees – Certain client contracts call for additional fees and or allocations of income tied to a certain percentage, generally
|
|
c.
|
Sub-advisory fees – Pursuant to agreements with other investment advisors, the Company receives a percentage of advisory fees received by such advisors from certain of their investment fund clients. These fees may be either asset- or performance-based. In addition, they may be subject to reduction by certain expenses as set forth in the respective agreements. Sub-advisory fee revenue which is asset-based is recognized ratably as the services are performed over the relevant contractual performance period. Sub-advisory fee revenue which is performance-based is recognized only when it becomes fixed and not subject to adjustment.
|
|
a.
|
Brokerage Commissions – Acting as agent, G.research buys and sells securities on behalf of its customers. Commissions are charged on the execution of securities transactions made on behalf of client accounts on an agency basis and are based on a rate schedule. G.research recognizes commission revenue when the related securities transactions are executed on trade date. G.research believes that the performance obligation is satisfied on trade date because that is when the underlying financial instrument or purchaser is identified, the pricing is agreed upon and the risks and rewards of ownership have been transferred to or from the customer. Commissions earned are typically collected from the clearing brokers utilized by G.research on a daily or weekly basis.
|
|
b.
|
Hard dollar payments – G.research provides research services to unrelated parties, for which direct payment is received. G.research may, or may not have contracts for such services. Where a contract for such services is in place, the contractual fee for the period is recognized ratably over the contract period, which is considered the period over which G.research satisfies its performance obligation. For payments where no research contract exists, revenue is not recognized until agreement is reached with the client at which time the performance obligation is considered to have been met and revenue is recognized.
|
|
c.
|
Selling concessions – G.research participates as a member of the selling group of underwritten equity offerings and receives compensation based on the difference between what its clients pay for the securities sold to its institutional clients and what the issuer receives. The terms of the selling concessions are set forth in contracts between G.research and the underwriter. Revenue is recognized on the trade date (the date on which the G.research purchases the securities from the issuer) for the portion G.research is contracted to buy. G.research believes that the trade date is the appropriate point in time to recognize revenue for securities underwriting transactions as there are no significant actions G.research needs to take subsequent to this date, and the issuer obtains the control and benefit of the capital markets offering at this point. Selling concessions earned are typically collected from the clearing brokers utilized by G.research on a daily or weekly basis.
|
|
d.
|
Sales manager fees – G.research participates as sales manager of at-the-market offerings of certain affiliated closed-end funds and receives a tiered percentage of proceeds as stipulated in agreements between G.research, the funds and the funds’ investment adviser. G.research recognizes sales manager fees upon sale of the related closed-end funds. Sales manager fees earned are fixed and typically collected from the clearing brokers utilized by G.research on a daily or weekly basis.
|
|
|
Three months ended June 30,
|
Six months ended June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Investment advisory and incentive fees
|
||||||||||||||||
|
Asset-based advisory fees
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Performance-based advisory fees
|
|
|
|
|
||||||||||||
|
Sub-advisory fees
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
Institutional research services
|
||||||||||||||||
|
Hard dollar payments
|
|
|
|
|
||||||||||||
|
Commissions
|
|
|
|
|
||||||||||||
|
Selling concessions
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
Other
|
||||||||||||||||
|
Underwriting fees
|
|
|
|
|
||||||||||||
|
Miscellaneous
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
||||||||||||||||
|
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
June 30, 2020
|
December 31, 2019
|
||||||||||||||
|
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
|
Debt - Trading Securities
|
||||||||||||||||
|
Government obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Total investments in government obligations
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
June 30, 2020
|
December 31, 2019
|
||||||||||||||
|
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
|
Equity Securities
|
||||||||||||||||
|
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Other investments
|
|
|
|
|
||||||||||||
|
Total investments in securities
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
June 30, 2020
|
December 31, 2019
|
||||||||||||||
|
Proceeds
|
Fair Value
|
Proceeds
|
Fair Value
|
|||||||||||||
|
Equity securities
|
||||||||||||||||
|
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other investments
|
|
|
|
|
||||||||||||
|
Total securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
June 30, 2020
|
December 31, 2019
|
||||||||||||||
|
Cost
|
Fair Value
|
Cost
|
Fair Value
|
|||||||||||||
|
Equity securities
|
||||||||||||||||
|
Closed-end funds
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Total investments in affiliated registered investment companies
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Asset Derivatives
|
Liability Derivatives
|
|||||||||||||||||
|
Statement of
|
Fair Value
|
Statement of
|
Fair Value
|
|||||||||||||||
|
Financial Condition
|
June 30,
|
December 31,
|
Financial Condition
|
June 30,
|
December 31,
|
|||||||||||||
|
Location
|
2020
|
2019
|
Location
|
2020
|
2019
|
|||||||||||||
|
Derivatives designated as hedging
|
||||||||||||||||||
|
instruments under FASB ASC 815-20
|
||||||||||||||||||
|
Foreign exchange contracts
|
Receivable from brokers
|
$
|
|
$
|
|
Payable to brokers
|
$
|
|
$
|
|
||||||||
|
Derivatives not designated as hedging
|
||||||||||||||||||
|
instruments under FASB ASC 815-20
|
||||||||||||||||||
|
Equity contracts
|
||||||||||||||||||
|
Investments in securities
|
$
|
|
$
|
|
Securities sold, not yet purchased
|
$
|
|
$
|
|
|||||||||
|
|
|
|
||||||||||||||||
|
Total derivatives
|
|
$
|
|
$
|
|
|
$
|
|
$
|
|
||||||||
|
Type of Derivative
|
Income Statement Location
|
Three Months ended June 30,
|
Six Months ended June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||||
|
Foreign exchange contracts
|
Net gain/(loss) from investments
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
||||||
|
Equity contracts
|
Net gain/(loss) from investments
|
|
|
(
|
)
|
(
|
)
|
||||||||||
|
Total
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||
|
Gross Amounts Not Offset in the
Statements of Financial Condition
|
||||||||||||||||||||||||
|
|
Gross
Amounts of
Recognized
Assets
|
Gross Amounts
Offset in the
Statements of
Financial Condition
|
Net Amounts of
Assets Presented
in the Statements
of Financial Condition
|
Financial
Instruments
|
Cash Collateral
Received
|
Net Amount
|
||||||||||||||||||
|
Swaps:
|
(In thousands)
|
|||||||||||||||||||||||
|
June 30, 2020
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
December 31, 2019
|
|
|
|
(
|
)
|
|
|
|||||||||||||||||
|
Gross Amounts Not Offset in the
Statements of Financial Condition
|
||||||||||||||||||||||||
|
|
Gross
Amounts of
Recognized
Liabilities
|
Gross Amounts
Offset in the
Statements of
Financial Condition
|
Net Amounts of
Liabilities Presented
in the Statements
of Financial Condition
|
Financial
Instruments
|
Cash Collateral
Pledged
|
Net Amount
|
||||||||||||||||||
|
Swaps:
|
(In thousands)
|
|||||||||||||||||||||||
|
June 30, 2020
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||||
|
December 31, 2019
|
|
|
|
(
|
)
|
|
|
|||||||||||||||||
|
|
June 30, 2020
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Assets
|
||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
||||||
|
Investments in debt securities
|
|
|
|
|||||||||
|
Investments in equity securities (including GBL stock)
|
|
|
|
|||||||||
|
Investments in affiliated investment companies
|
|
(
|
)
|
|
||||||||
|
Investments in partnerships
|
|
(
|
)
|
|
||||||||
|
Receivable from brokers
|
|
|
|
|||||||||
|
Investment advisory fees receivable
|
|
(
|
)
|
|
||||||||
|
Other assets
|
|
|
|
|||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
||||||
|
Liabilities and equity
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
||||||
|
Accrued expenses and other liabilities
|
|
|
|
|||||||||
|
Redeemable noncontrolling interests
|
|
|
|
|||||||||
|
Total equity
|
|
|
|
|||||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
$
|
|
||||||
|
|
December 31, 2019
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Assets
|
||||||||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
||||||
|
Investments in debt securities
|
|
|
|
|||||||||
|
Investments in equity securities (including GBL stock)
|
|
|
|
|||||||||
|
Investments in affiliated investment companies
|
|
(
|
)
|
|
||||||||
|
Investments in partnerships
|
|
(
|
)
|
|
||||||||
|
Receivable from brokers
|
|
|
|
|||||||||
|
Investment advisory fees receivable
|
|
(
|
)
|
|
||||||||
|
Other assets
|
|
|
|
|||||||||
|
Total assets
|
$
|
|
$
|
|
$
|
|
||||||
|
Liabilities and equity
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
||||||
|
Accrued expenses and other liabilities
|
|
|
|
|||||||||
|
Redeemable noncontrolling interests
|
|
|
|
|||||||||
|
Total equity
|
|
|
|
|||||||||
|
Total liabilities and equity
|
$
|
|
$
|
|
$
|
|
||||||
|
|
Three Months Ended June 30, 2020
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Total expenses
|
|
|
|
|||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Total other income, net
|
|
|
|
|||||||||
|
Income before income taxes
|
|
|
|
|||||||||
|
Income tax expense
|
|
|
|
|||||||||
|
Net income before NCI
|
|
|
|
|||||||||
|
Net income/(loss) attributable to noncontrolling interests
|
(
|
)
|
|
|
||||||||
|
Net Income
|
$
|
|
$
|
|
$
|
|
||||||
|
|
Three Months Ended June 30, 2019
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Total expenses
|
|
|
|
|||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Total other income, net
|
|
|
|
|||||||||
|
Income/(loss) before income taxes
|
(
|
)
|
|
(
|
)
|
|||||||
|
Income tax benefit
|
(
|
)
|
|
(
|
)
|
|||||||
|
Net income/(loss) before NCI
|
(
|
)
|
|
|
||||||||
|
Net income attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Net loss
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
|
Six Months Ended June 30, 2020
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
|
$
|
|
$
|
|
||||||
|
Total expenses
|
|
|
|
|||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Total other income/(expense), net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Loss before income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Income tax benefit
|
(
|
)
|
|
(
|
)
|
|||||||
|
Net loss before NCI
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net loss attributable to noncontrolling interests
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Net loss
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
||||
|
|
Six Months Ended June 30, 2019
|
|||||||||||
|
Prior to
Consolidation
|
Consolidated
Entities
|
As Reported
|
||||||||||
|
Total revenues
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
|
Total expenses
|
|
|
|
|||||||||
|
Operating loss
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
|
Total other income, net
|
|
|
|
|||||||||
|
Income before income taxes
|
|
|
|
|||||||||
|
Income tax expense
|
|
|
|
|||||||||
|
Net income before NCI
|
|
|
|
|||||||||
|
Net income attributable to noncontrolling interests
|
|
|
|
|||||||||
|
Net income
|
$
|
|
$
|
|
$
|
|
||||||
|
|
June 30,
2020
|
December 31,
2019
|
||||||
|
Cash and cash equivalents
|
$
|
|
$
|
|
||||
|
Investments in securities
|
|
|
||||||
|
Receivable from brokers
|
|
|
||||||
|
Investments in partnerships and affiliates
|
|
|
||||||
|
Accrued expenses and other liabilities
|
(
|
)
|
(
|
)
|
||||
|
Redeemable noncontrolling interests
|
(
|
)
|
(
|
)
|
||||
|
AC Group’s net interests in consolidated VIEs
|
$
|
|
$
|
|
||||
|
|
June 30, 2020
|
|||||||||||||||
|
Assets
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
|
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Investments in debt securities:
|
||||||||||||||||
|
Trading - Gov’t obligations
|
|
|
||||||||||||||
|
Total investments in debt securities
|
|
|
|
|
||||||||||||
|
Investments in equity securities (including GBL stock):
|
||||||||||||||||
|
Common stocks
|
|
|
|
|
||||||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Total investments in equity securities
|
|
|
|
|
||||||||||||
|
Investments in affiliated registered investment companies:
|
||||||||||||||||
|
Closed-end funds
|
|
|
|
|
||||||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Total investments in affiliated registered investment companies
|
|
|
|
|
||||||||||||
|
Total investments held at fair value
|
|
|
|
|
||||||||||||
|
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Liabilities
|
||||||||||||||||
|
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
December 31, 2019
|
|||||||||||||||
|
Assets
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable
Inputs (Level 2)
|
Significant
Unobservable
Inputs (Level 3)
|
Total
|
||||||||||||
|
Cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Investments in debt securities:
|
||||||||||||||||
|
Trading - Gov’t obligations
|
|
|
|
|
||||||||||||
|
Total investments in debt securities
|
|
|
|
|
||||||||||||
|
Investments in equity securities (including GBL stock):
|
||||||||||||||||
|
Common stocks
|
|
|
|
|
||||||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Total investments in equity securities
|
|
|
|
|
||||||||||||
|
Investments in affiliated registered investment companies:
|
||||||||||||||||
|
Closed-end funds
|
|
|
|
|
||||||||||||
|
Mutual funds
|
|
|
|
|
||||||||||||
|
Total investments in affiliated registered investment companies
|
|
|
|
|
||||||||||||
|
Total investments held at fair value
|
|
|
|
|
||||||||||||
|
Total assets at fair value
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Liabilities
|
||||||||||||||||
|
Common stocks
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
Other
|
|
|
|
|
||||||||||||
|
Securities sold, not yet purchased
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
|
|
Three months ended June 30, 2020
|
Three months ended June 30, 2019
|
||||||||||||||||||||||
|
Common
Stocks
|
Other
|
Total
|
Common
Stocks
|
Other
|
Total
|
|||||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Total gains/(losses)
|
|
|
|
|
|
|
||||||||||||||||||
|
Purchases
|
|
|
|
|
|
|
||||||||||||||||||
|
Sales
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
|
Transfers
|
|
|
|
|
|
|
||||||||||||||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Changes in net unrealized gain/(loss) included in Net gain/(loss) from investments related to level 3 assets still held as of the reporting date
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
|
Six months ended June 30, 2020
|
Six months ended June 30, 2019
|
||||||||||||||||||||||
|
Common
Stocks
|
Other
|
Total
|
Common
Stocks
|
Other
|
Total
|
|||||||||||||||||||
|
Beginning balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Total gains/(losses)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||||
|
Purchases
|
|
|
|
|
|
|
||||||||||||||||||
|
Sales
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
|
Transfers
|
|
|
|
|
|
|
||||||||||||||||||
|
Ending balance
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
|
Changes in net unrealized gain/(loss) included in Net gain/(loss) from investments related to level 3 assets still held as of the reporting date
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
|
|||||||||
|
|
Three Months Ended June 30,
|
|||||||
|
(amounts in thousands, except per share amounts)
|
2020
|
2019
|
||||||
|
Basic:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
|
$
|
(
|
)
|
|||
|
Weighted average shares outstanding
|
|
|
||||||
|
Basic net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share
|
$
|
|
$
|
(
|
)
|
|||
|
|
||||||||
|
Diluted:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
|
$
|
(
|
)
|
|||
|
Weighted average share outstanding
|
|
|
||||||
|
Total
|
|
|
||||||
|
Diluted net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share
|
$
|
|
$
|
(
|
)
|
|||
|
|
Six Months Ended June 30,
|
|||||||
|
(amounts in thousands, except per share amounts)
|
2020
|
2019
|
||||||
|
Basic:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
(
|
)
|
$
|
|
|||
|
Weighted average shares outstanding
|
|
|
||||||
|
Basic net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share
|
$
|
(
|
)
|
$
|
|
|||
|
|
||||||||
|
Diluted:
|
||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
(
|
)
|
$
|
|
|||
|
Weighted average share outstanding
|
|
|
||||||
|
Total
|
|
|
||||||
|
Diluted net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share
|
$
|
(
|
)
|
$
|
|
|||
| ITEM 2: |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (INCLUDING QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK) (“MD&A”)
|
|
(in thousands, except per share data)
|
Three months ended June 30,
|
Six months ended June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
|||||||||||||
|
Revenues
|
||||||||||||||||
|
Investment advisory and incentive fees
|
$
|
1,859
|
$
|
2,713
|
$
|
4,559
|
$
|
5,446
|
||||||||
|
Institutional research services
|
1,104
|
2,076
|
2,478
|
3,989
|
||||||||||||
|
Other
|
174
|
32
|
469
|
38
|
||||||||||||
|
Total revenues
|
3,137
|
4,821
|
7,506
|
9,473
|
||||||||||||
|
Expenses
|
||||||||||||||||
|
Compensation
|
3,538
|
5,584
|
7,731
|
11,480
|
||||||||||||
|
Stock-based compensation
|
447
|
284
|
(371
|
)
|
699
|
|||||||||||
|
Other operating expenses
|
3,295
|
2,104
|
5,384
|
8,321
|
||||||||||||
|
Total expenses
|
7,280
|
7,972
|
12,744
|
20,500
|
||||||||||||
|
Operating loss
|
(4,143
|
)
|
(3,151
|
)
|
(5,238
|
)
|
(11,027
|
)
|
||||||||
|
Other income/(expense)
|
||||||||||||||||
|
Net gain/(loss) from investments
|
51,714
|
(234
|
)
|
(50,376
|
)
|
34,745
|
||||||||||
|
Interest and dividend income
|
1,227
|
3,295
|
3,537
|
7,081
|
||||||||||||
|
Interest expense
|
(65
|
)
|
(35
|
)
|
(114
|
)
|
(79
|
)
|
||||||||
|
Shareholder-designated contribution
|
2
|
-
|
(225
|
)
|
-
|
|||||||||||
|
Total other income/(expense), net
|
52,878
|
3,026
|
(47,178
|
)
|
41,747
|
|||||||||||
|
Income/(loss) before income taxes
|
48,735
|
(125
|
)
|
(52,416
|
)
|
30,720
|
||||||||||
|
Income tax expense/(benefit)
|
11,110
|
(277
|
)
|
(12,689
|
)
|
5,914
|
||||||||||
|
Net income/(loss)
|
37,625
|
152
|
(39,727
|
)
|
24,806
|
|||||||||||
|
Net income/(loss) attributable to noncontrolling interests
|
2,388
|
1,084
|
(1,609
|
)
|
2,591
|
|||||||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders
|
$
|
35,237
|
$
|
(932
|
)
|
$
|
(38,118
|
)
|
$
|
22,215
|
||||||
|
Net income/(loss) attributable to Associated Capital Group, Inc.’s shareholders per share:
|
||||||||||||||||
|
Basic
|
$
|
1.57
|
$
|
(0.04
|
)
|
$
|
(1.70
|
)
|
$
|
0.98
|
||||||
|
Diluted
|
$
|
1.57
|
$
|
(0.04
|
)
|
$
|
(1.70
|
)
|
$
|
0.98
|
||||||
|
|
% Change From
|
|||||||||||||||||||
|
June 30,
2020
|
December 31,
2019
|
June 30,
2019
|
December 31,
2019
|
June 30,
2019
|
||||||||||||||||
|
Event Merger Arbitrage
|
$
|
1,147
|
$
|
1,525
|
$
|
1,422
|
(24.8
|
)
|
(19.3
|
)
|
||||||||||
|
Event-Driven Value
|
104
|
132
|
127
|
(21.2
|
)
|
(18.1
|
)
|
|||||||||||||
|
Other
|
54
|
59
|
58
|
(8.5
|
)
|
(6.9
|
)
|
|||||||||||||
|
Total AUM
|
$
|
1,305
|
$
|
1,716
|
$
|
1,607
|
(24.0
|
)
|
(18.8
|
)
|
||||||||||
|
|
March 31,
2020
|
Market
appreciation/
(depreciation)
|
Net cash
flows
|
June 30,
2020
|
||||||||||||
|
Event Merger Arbitrage
|
$
|
1,312
|
$
|
83
|
$
|
(248
|
)
|
$
|
1,147
|
|||||||
|
Event-Driven Value
|
112
|
8
|
(16
|
)
|
104
|
|||||||||||
|
Other
|
49
|
6
|
(1
|
)
|
54
|
|||||||||||
|
Total AUM
|
$
|
1,473
|
$
|
97
|
$
|
(265
|
)
|
$
|
1,305
|
|||||||
|
|
Six months ended June 30,
|
|||||||
|
2020
|
2019
|
|||||||
|
Cash flows provided by (used in):
|
||||||||
|
Operating activities
|
$
|
(254,967
|
)
|
$
|
(36,080
|
)
|
||
|
Investing activities
|
(10,016
|
)
|
(3,856
|
)
|
||||
|
Financing activities
|
(9,200
|
)
|
(8,126
|
)
|
||||
|
Net increase (decrease)
|
(274,183
|
)
|
(48,062
|
)
|
||||
|
Cash and cash equivalents at beginning of period
|
348,588
|
409,564
|
||||||
|
Increase in cash from consolidation
|
-
|
62
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
74,405
|
$
|
361,564
|
||||
| Item 3. |
Quantitative and Qualitative Disclosures About Market Risk
|
| Item 4. |
Controls and Procedures
|
| • |
the adverse effect from a decline in the securities markets
|
| • |
a decline in the performance of our products
|
| • |
a general downturn in the economy
|
| • |
changes in government policy or regulation
|
| • |
changes in our ability to attract or retain key employees
|
| • |
unforeseen costs and other effects related to legal proceedings or investigations of governmental and self-regulatory organizations
|
| Item 1. |
Legal Proceedings
|
| Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
Period
|
Total
Number of
Shares
Repurchased
|
Average
Price Paid Per
Share, net of
Commissions
|
Total Number of
Shares Repurchased as
Part of Publicly
Announced Plans
or Programs
|
Maximum
Number of Shares
That May Yet Be
Purchased Under
the Plans or Programs
|
||||||||||||
|
04/01/20 - 04/30/20
|
6,049
|
$
|
34.77
|
6,049
|
1,006,516
|
|||||||||||
|
05/01/20 - 05/31/20
|
16,622
|
34.33
|
16,622
|
989,894
|
||||||||||||
|
06/01/20 - 06/30/20
|
8,286
|
34.66
|
8,286
|
981,608
|
||||||||||||
|
Totals
|
30,957
|
$
|
34.51
|
30,957
|
||||||||||||
| Item 6. |
(a) Exhibits
|
|
Certification of CEO pursuant to Rule 13a-14(a).
|
|
|
Certification of CAO pursuant to Rule 13a-14(a).
|
|
|
Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of CAO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
|
|
|
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document.
|
|
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
|
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
|
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
104
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|